- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||ozanezumab|
|Search PubMed titles||ozanezumab|
|Search PubMed titles/abstracts||ozanezumab|
|Ozanezumab is a humanised mouse monoclonal antibody targeting NOGO-A (reticulon-4, RTN4). This antibody is in GlaxoSmithKline's development pipeline of drugs for rare diseases, in this case amyotrophic lateral sclerosis (ALS aka motor neurone disease or MND) and was also investigated for multiple sclerosis (MS).
Although peptide sequences for ozanezumab are available, a BLAST search provided no exact matches with patented protein sequences